Carotid Artery Narrowing Without Symptoms: How Modern Ultrasound Predicts Stroke Risk

Table of Contents

• Key Points
• Background: The Silent Danger of Carotid Stenosis
• The Role of Duplex Ultrasound: A First-Line Detection Tool
• Best Medical Therapy: The Foundation of Care for Every Patient
• Declining Stroke Rates: A Turning Point in Treatment Strategy
• Beyond the Degree of Narrowing: Why Plaque Character Matters
• Ultrasound Features of a Vulnerable Carotid Plaque
• Clinical Implications: Who Might Still Need Surgery or Stenting?
• Limitations of the Current Evidence
• Recommendations for Patients
• Frequently Asked Questions
• Source Information

Key Points

• All patients with asymptomatic carotid stenosis need medical therapy.
• Stroke rates in asymptomatic carotid stenosis have declined due to better medications.
• Plaque character, not just narrowing degree, helps predict stroke risk.
• High-risk plaque features include dark appearance, ulceration, and intraplaque blood vessels.
• Surgery or stenting is reserved for patients with high-risk plaque features or progression.

Background: The Silent Danger of Carotid Stenosis

The carotid arteries are the two main blood vessels on each side of your neck that carry oxygen-rich blood to your brain. When fatty deposits, or plaques, build up inside these arteries, the condition is known as carotid stenosis (narrowing of the carotid artery).

Many people live with carotid stenosis without experiencing any warning signs. When the narrowing is discovered incidentally—for example, during a routine ultrasound for an unrelated reason—it is called asymptomatic carotid stenosis (ACS). The word "asymptomatic" means the patient has not experienced a transient ischemic attack (TIA, sometimes called a "mini-stroke") or a stroke on the side of the brain served by that artery.

The danger is real, however. The review explains that distal embolization originating from an ipsilateral asymptomatic carotid stenosis is the cause of a substantial proportion of first-ever ischemic strokes. In plain terms: tiny pieces of plaque or blood clots can break off from the narrowed artery (on the same side of the neck as the stroke) and travel downstream into the brain, blocking a smaller blood vessel and causing a stroke. This is often a person's very first stroke—there are no prior warnings.

The Role of Duplex Ultrasound: A First-Line Detection Tool

When a doctor suspects carotid artery disease, or when a patient has risk factors such as high blood pressure, diabetes, smoking, or high cholesterol, the first imaging test recommended is duplex ultrasound. This is a painless, non-invasive test that combines two techniques in a single examination:

• B-mode ultrasound (brightness mode): Produces a two-dimensional grayscale image showing the anatomy of the artery wall and any plaque attached to it.
• Doppler ultrasound: Measures the speed and direction of blood flowing through the artery. When a vessel is narrowed, blood moves faster through the tight spot, and these flow velocity changes allow the doctor to estimate the degree of stenosis (percentage of blockage).

Duplex ultrasound is recommended as the first-line imaging method to detect and evaluate the extent and severity of extracranial carotid stenoses—that is, narrowing of the carotid arteries in the neck, outside the skull.

This is considered an extension of the physical exam. The ultrasound is widely available, does not involve radiation or contrast dye injections, can be repeated safely over time to monitor changes, and provides valuable information about both the severity of the narrowing and the nature of the plaque itself. The review article categorizes the severity of stenosis based on hemodynamic criteria, which simply means blood-flow measurements obtained through Doppler ultrasound.

Best Medical Therapy: The Foundation of Care for Every Patient

The review is unequivocal on one point: all patients with asymptomatic carotid stenosis need best cardiovascular medical therapy. This is not an optional recommendation—it applies to every single patient, regardless of whether they ultimately undergo a procedure. The components of this therapy include:

• Smoking cessation strategies: Smoking is a major driver of atherosclerosis, and quitting is one of the most impactful steps a patient can take.
• Statins: These cholesterol-lowering medications do more than lower "bad" LDL cholesterol—they also stabilize plaque, making it less likely to rupture and send debris to the brain.
• Antihypertensive drugs: Lowering blood pressure reduces the force of blood flow against the plaque and decreases the risk of a stroke-causing event.
• Antiplatelet therapy: Medications such as low-dose aspirin or clopidogrel reduce the ability of blood platelets to clump together and form clots that could break off and travel to the brain.

This combination of therapies addresses the underlying disease process throughout the entire body, not just in the carotid artery. Patients with ACS typically have atherosclerosis elsewhere, so treating the whole vascular system provides far-reaching protection against heart attacks and other vascular events.

Declining Stroke Rates: A Turning Point in Treatment Strategy

One of the most important developments in recent years is that the risk of stroke in patients with asymptomatic carotid stenosis has fallen dramatically. The review states that the annual stroke rate in patients with ACS has significantly declined during the last years due to improvement in medical therapy.

Why does this matter? For decades, the standard approach to a high-grade asymptomatic carotid stenosis (typically a blockage of 60% to 99%) was to offer a preventive procedure—either carotid endarterectomy (surgical removal of the plaque) or carotid stenting (placing a mesh tube to hold the artery open). The logic was straightforward: if the artery is severely narrowed, fix it before it causes a stroke.

But as medical therapy improved, the risk-to-benefit equation shifted. The risk of stroke from the stenosis itself dropped substantially, to the point where, for many patients, the risks of the procedure (which include surgical stroke, heart attack, nerve injury, and bleeding) began to outweigh the potential benefit. The review concludes that surgical prophylactic carotid endarterectomy or carotid stenting are no longer recommended routinely in all patients with high-grade ACS.

This is a personalized medicine message: blanket recommendations for surgery have been replaced by an individualized approach that takes into account each patient's specific risk profile.

Beyond the Degree of Narrowing: Why Plaque Character Matters

The traditional way to gauge stroke risk in patients with carotid stenosis has been to measure how severely the artery is narrowed, using the hemodynamic (blood-flow) criteria on duplex ultrasound. A 70% stenosis was considered riskier than a 50% stenosis, and so on. The degree of narrowing is still important, but the review emphasizes that it is no longer the only—or even the most important—factor.

Several studies now demonstrate that not only the grade of stenosis based on hemodynamic criteria on duplex ultrasound increases the ipsilateral stroke risk, but also morphological characteristics are associated with more vulnerable plaque and a higher risk of stroke. In other words, a moderately narrowed artery containing a dangerous, unstable plaque could pose a greater threat than a severely narrowed artery containing a stable, calcified plaque.

The concept of the vulnerable plaque has transformed how doctors think about stroke prevention. A vulnerable plaque is one that is prone to rupture or erosion. When it breaks apart, debris and clots are released into the bloodstream and travel to the brain. The review highlights that morphological features visible on ultrasound may help identify which plaques are truly dangerous.

Ultrasound Features of a Vulnerable Carotid Plaque

The review identifies several specific ultrasound findings that have been studied as predictors of a vulnerable, higher-risk carotid stenosis. These are features that can be seen either during the standard B-mode ultrasound examination or during a more advanced technique called contrast-enhanced ultrasound (in which a harmless microbubble contrast agent is injected into a vein to highlight blood flow within the plaque itself).

The key risk features identified in the review are:

• A high progression rate of the grade of stenosis on duplex ultrasound: If follow-up ultrasounds show that the narrowing is rapidly worsening over time, this suggests an unstable process that may be more likely to cause a stroke.
• Hypoechogenicity on B-mode ultrasound: This means the plaque appears darker on the grayscale image. Dark appearance indicates a soft, lipid-rich (fatty) plaque rather than a hard, calcified one. Such soft plaques are more prone to rupture.
• Higher plaque area: The overall size of the plaque, measured on ultrasound images, correlates with the burden of disease and with stroke risk.
• Surface irregularities and ulceration on B-mode ultrasound: A smooth plaque surface is more stable. An irregular, rough surface—or one with a visible ulcer (a crater-like defect)—is a dangerous sign. Ulcers act as sites where clots can form and break off.
• Intraplaque vascularization on contrast-enhanced ultrasound: Healthy plaques have very few blood vessels inside them. When new, fragile microvessels grow into the plaque (a process called neovascularization or intraplaque vascularization), they can bleed, causing the plaque to expand or rupture. Contrast-enhanced ultrasound can visualize these tiny vessels, and their presence is a marker of vulnerability.

Why are these features so relevant? Because they reflect the biology of the plaque—what it is actually made of and how unstable it is—rather than just the physical narrowing it causes. A patient whose artery is only 50% narrowed but has an ulcerated, hypoechoic plaque with intraplaque vascularization may face a higher stroke risk than a patient with a 90% narrowing but a smooth, calcified, stable plaque.

Clinical Implications: Who Might Still Need Surgery or Stenting?

These additional morphological features are not purely academic. The review notes that they may be useful to select a subgroup of patients with ACS who may benefit from interventions.

If a patient has high-risk plaque features, the estimated stroke risk from the carotid disease may exceed the risk of surgery or stenting, making a procedure worthwhile. Conversely, if a patient has a highly calcified, stable plaque and no adverse features, the expected benefit of a procedure would be very small, and medical therapy alone would be the safest and most appropriate path.

In practice, this means that the decision to proceed with carotid endarterectomy or carotid stenting is becoming more nuanced. The modern cardiovascular team—composed of vascular surgeons, interventional radiologists, cardiologists, and angiologists—weighs the patient's overall life expectancy, the degree of stenosis, the morphology of the plaque, and the center's own surgical complication rates before making a recommendation.

This is important information for patients facing these decisions. Being told, "You have a 70% carotid stenosis," is no longer enough to make a treatment decision. The ultrasound report must be interpreted in the context of plaque features, disease progression, and overall health.

Limitations of the Current Evidence

While the evidence supporting the role of plaque morphology is growing, the review itself acknowledges that the field still has important gaps. First, the original article is a review article, not a randomized controlled trial—it synthesizes the findings of prior studies rather than contributing new patient data. Second, the predictive value of these ultrasound features, while statistically associated with stroke risk in research studies, has not yet been fully validated in large-scale prospective trials that would allow doctors to confidently assign a precise risk percentage to each patient.

There is also inherent operator variability in ultrasound. Carotid plaque characterization relies on the skill and experience of the sonographer and interpreting physician. The assessment of "hypoechogenicity" or "surface irregularities" involves a subjective component, although standardized scoring systems are being developed. Contrast-enhanced ultrasound requires intravenous access and the injection of a contrast agent, which is not universally available in all imaging centers.

Finally, because stroke rates in medically treated patients with asymptomatic carotid stenosis have declined so substantially, conducting new trials large enough to prove which morphological features can predict benefit from intervention has become a major challenge. The review calls attention to these limitations while affirming that the available data point in a consistent direction.

Recommendations for Patients

Based on the findings of this review and the broader literature, patients with asymptomatic carotid stenosis should consider the following:

1. Take medical therapy seriously. If you have been prescribed a statin, blood pressure medication, or antiplatelet drug, take it daily as directed. These medications work quietly in the background to stabilize plaques and reduce stroke risk. Never stop them without discussing with your doctor.
2. Quit smoking—completely. If you smoke, the most powerful single step you can take to protect your brain is to stop. Ask your doctor about nicotine replacement therapy, counseling, or prescription medications that can double your chances of success.
3. Ask for a full ultrasound report. When you undergo a carotid duplex ultrasound, ask your doctor to explain not only the percentage of stenosis but also the plaque characteristics—whether it is fatty or calcified, whether the surface is smooth or irregular, and whether contrast-enhanced ultrasound showed vascularity within the plaque.
4. Attend scheduled follow-up ultrasounds. Since a high rate of stenosis progression is a risk marker, serial ultrasounds (often performed every 6 to 12 months) are important for detecting changes over time.
5. Do not assume surgery is required. If you are told you have a high-grade asymptomatic carotid stenosis, ask whether best medical therapy alone might be appropriate. Surgical treatment (endarterectomy) or stenting may be reserved for patients with high-risk plaque features, rapidly progressive stenosis, or symptoms.
6. If a procedure is recommended, ask why. Your doctors should be able to explain which specific features of your plaque or your clinical situation make you a candidate for intervention. A decision to operate should be based on your estimated individualized risk, not a blanket rule.

Patients should also remember that carotid stenosis is a marker of generalized atherosclerosis (hardening of the arteries throughout the body). A heart-healthy lifestyle—including regular physical activity, a Mediterranean-style diet, weight management, and blood sugar control if you have diabetes—protects the carotid arteries and the rest of the vascular system at the same time.

Frequently Asked Questions

What is asymptomatic carotid stenosis?

Asymptomatic carotid stenosis is a narrowing of one of the main neck arteries supplying blood to the brain, with no prior mini-stroke or stroke on that side. It is often discovered incidentally during an ultrasound for another reason. The danger is that plaque pieces or clots can break off and cause a first-ever stroke.

How is carotid artery narrowing detected?

Duplex ultrasound is the first-line test. It combines B-mode imaging, which shows the artery wall and plaque, with Doppler ultrasound, which measures blood flow speed. Faster flow indicates narrowing. This painless test involves no radiation or contrast dye and can be repeated safely to monitor changes over time.

Why is surgery or stenting no longer recommended for every patient with asymptomatic carotid stenosis?

Recent improvements in medical therapy have dramatically lowered stroke rates in patients with asymptomatic carotid stenosis. For many patients, the risks of surgery or stenting, such as surgical stroke, heart attack, or nerve injury, now outweigh the potential benefit. Therefore, these procedures are reserved for higher-risk individuals rather than offered routinely.

Which ultrasound features make a carotid plaque vulnerable?

A vulnerable plaque may appear dark (hypoechoic) on B-mode ultrasound, indicating a soft, lipid-rich plaque. Other risk features include a high rate of stenosis progression over time, a larger plaque area, surface irregularities or ulceration, and new blood vessel growth inside the plaque seen on contrast-enhanced ultrasound.

Who might still need surgery or carotid stenting?

Patients with high-risk plaque features, such as an ulcerated, hypoechoic plaque with intraplaque vascularization or a rapidly progressing stenosis, may benefit from intervention. The decision also considers overall life expectancy and the center's surgical complication rates. A procedure is recommended when the estimated stroke risk from the carotid disease exceeds the risk of the intervention.

What lifestyle changes are recommended for patients with asymptomatic carotid stenosis?

Quit smoking completely, as it is the most powerful single step. Take prescribed medications daily. Follow a heart-healthy lifestyle with regular physical activity, a Mediterranean-style diet, weight management, and blood sugar control if diabetic. Attend scheduled follow-up ultrasounds, often every 6 to 12 months, to monitor for progression.

I have asymptomatic carotid stenosis and was told I don't need surgery—when should I get a second opinion on whether stenting or endarterectomy is necessary?

For asymptomatic carotid stenosis, surgery or stenting is no longer routinely recommended for everyone; stroke risk has fallen sharply with medical therapy. A second opinion is especially useful when a procedure is recommended despite no symptoms, because the decision now depends on plaque features—dark, ulcerated, rapidly progressing, or showing new blood vessels—plus your overall health and your center's complication rates. It is also reasonable to seek one if you are unsure why surgery was either advised or ruled out for your specific plaque. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

This patient-friendly article is based on a peer-reviewed review published in a Swiss medical journal. Here are the details of the original source:

• Original title: "Duplex ultrasound in cerebrovascular disease - asymptomatic carotid stenosis" [Article in German]
• Author: Daniel Staub
• Affiliation: Klinik für Angiologie, Universitätsspital Basel, Universität Basel (Clinic for Angiology, University Hospital Basel, University of Basel, Switzerland)
• Journal: Therapeutische Umschau (Therapeutic Review), 2018; Volume 75, Issue 8, pages 489–495
• DOI: 10.1024/0040-5930/a001029
• PMID: 31038044
• Publication date: 2018 (abstract available in English and German)

Note: This article is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding a medical condition. Because this review was published in 2018, readers are encouraged to consult their healthcare team for the most current treatment recommendations.